KRISTINA NEAGOS: Open Payments
NPI 1053621565 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 42 payments from 6 companies in 2025. Trend: 2023 $930 · 2024 $1,019 · 2025 $923
Food & beverage: $923
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $430 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $172 |
| Madrigal Pharmaceuticals | 6 | $167 |
| GENZYME CORPORATION | 3 | $98 |
| Aimmune Therapeutics, Inc. | 1 | $32 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
Products named: RINVOQ, XIFAXAN, REZDIFFRA, DUPIXENT, SKYRIZI, CREON, VOWST, REBYOTA.
Industry payments across CA — which companies pay providers there.
